Evidence map›Paper›PMID 20142358›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

c-Myb promotes the survival of CD4+CD8+ double-positive thymocytes through upregulation of Bcl-xL.

Joan Yuan, Rowena B Crittenden, Timothy P Bender

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Development of αβ T Cells with Innate Functions.Advances in experimental medicine and biology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Cytokines, Transcription Factors, and the Initiation of T-Cell Development.Cold Spring Harbor perspectives in biology · 2018
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Joan YuanDepartment of Microbiology, Beirne B Carter Center for Immunology Research, University of Virginia Health System, Charlottesville, VA 22908, USA.
Rowena B Crittenden
Timothy P Bender
Carter Center · US

Funding

CONDITIONAL MUTAGENESIS TO STUDY C MYB FUNCTIONR01CA085842 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BENDER, TIMOTHY P. · 2001 to 2011
$3.2M
CONDITIONAL MUTATIONS AT THE C-MYB LOCUSF06TW002297 · FIC · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI BENDER, TIMOTHY P. · 1998 to 1998
–
FIC NIH HHS F06 TW002297NCI NIH HHS CA85842NCI NIH HHS R01 CA085842
6 · The paper itself

Abstract

Mechanisms that regulate the lifespan of CD4(+)CD8(+) double-positive (DP) thymocytes help shape the peripheral T cell repertoire. However, the molecular mechanisms controlling DP thymocyte survival remain poorly understood. The Myb proto-oncogene encodes a transcription factor required during multiple stages of T cell development. We demonstrate that Myb mRNA expression is upregulated as thymocytes differentiate from the double-negative into the metabolically quiescent, small, preselection DP stage during T cell development. Using a conditional deletion mouse model, we demonstrate that Myb-deficient DP thymocytes undergo premature apoptosis, resulting in a limited Tcralpha repertoire biased toward 5' Jalpha segment usage. Premature apoptosis occurs specifically in the small preselection DP compartment in an alphabetaTCR-independent manner and is a consequence of decreased Bcl-xL expression. Forced Bcl-xL expression is able to rescue survival, and reintroduction of c-Myb restores both Bcl-xL expression and the small preselection DP compartment. We further demonstrate that c-Myb promotes transcription at the Bcl2l1 locus via a genetic pathway that is independent of the expression of T cell-specific factor-1 or RORgammat, two transcription factors that induce Bcl-xL expression in T cell development. Thus, Bcl-xL is a novel mediator of c-Myb activity during normal T cell development.

Indexed as

AnimalsApoptosisbcl-X ProteinCD4 AntigensCD8 AntigensCell DifferentiationCell SurvivalClone CellsCoculture TechniquesIntegrasesMiceMice, KnockoutMice, TransgenicProto-Oncogene Proteins c-mybThymus GlandT-Lymphocyte SubsetsBcl2l1 protein, mousebcl-X ProteinCD4 AntigensCD8 AntigensCre recombinaseIntegrasesProto-Oncogene Proteins c-myb

Identifiers

PMID20142358
PMCPMC2856624
OpenAlexW1711584008

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.